Why do 40% of biotech startups fail post-seed funding? Understand the R&D valley of death, VC trends, and new funding strategies.
·
·
8 min read
TOYO's 2026 plan targets 30% renewable project growth in green hydrogen and SAF. See where they're investing and why it matters for sustainable energy.
·
·
7 min read
Do ethical practices pay off? Companies with strong CSR saw 20% higher stock valuations. See how transparency impacts profits and trust.
·
·
7 min read
Got a CBP tariff refund? Understand post-refund legal risks and avoid penalties. Learn why documentation for 5 years matters.
·
·
8 min read
Robotics investment surged past $10 billion in 2025. See why this industrial automation boom matters and how businesses can scale effectively.
·
·
6 min read
NACS Show 2026 tackles the convenience store foodservice labor shortage. See how new tech, AI scheduling, and training can boost staffing & profit.
·
·
5 min read
Why did CSL invest in Alentis? This deal shows how big pharma is changing early biotech funding and targeting fibrotic diseases. What's next for 2026?
·
·
8 min read
Genentech and Alector expand their 2026 deal for immunoneurology. See what this biotech partnership means for new drug discovery and R&D strategies.
·
·
4 min read
Why Foghorn Therapeutics cut 40% of its staff despite $280M cash. See how funding shifts impact biotech innovation and what's next.
·
·
7 min read
Why are US companies bringing jobs home? Learn how supply chain issues are spurring reshoring, creating 2 million new jobs by 2030, and impacting wages.
·
·
8 min read